<DOC>
	<DOCNO>NCT01432379</DOCNO>
	<brief_summary>This post authorization observational study monitor utilization practice describe safety profile BOTOX® clinical practice prophylactic treatment headache adult patient chronic migraine .</brief_summary>
	<brief_title>BOTOX® Prophylaxis Patients With Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis chronic migraine Willing use BOTOX® preventative treatment migraine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>